Adam Peyton
Impact in
- Hepatology top 5%
- Liver Diseases and Immunity
- Liver physiology and pathology
- Liver Disease and Transplantation
- Hepatitis C virus research
- Epidemiology top 10%
- Liver Disease Diagnosis and Treatment
Papers in
-
- Liver Diseases and Immunity 3
- Hepatitis C virus research 1
-
- Gallbladder and Bile Duct Disorders 2
- Co-authors
- Patricia W. Slattum (1 shared paper)Rita A. Jablonski (1 shared paper)Peter A. Boling (1 shared paper)F. Ellen Netting (1 shared paper)Iris A. Parham (1 shared paper)Zamir Brelvi (1 shared paper)Maria Del Pilar Solis Hernandez (1 shared paper)Lennox J. Jeffers (1 shared paper)
- Journals
- Journal of Hepatology (2 papers)Gastroenterology (1 paper)The American Journal of Gastroenterology (1 paper)Annals of Hepatology (1 paper)VCU Scholars Compass (Virginia Commonwealth University) (1 paper)
- Partner nations
- United States
In The Last Decade
Adam Peyton
7 papers receiving 419 citations
Adam Peyton's Hit Papers
Peers
Comparison fields: 5 of 42
- Hepatology 157
- Epidemiology 311
- Endocrinology, Diabetes and Metabolism 106
- Cell Biology 63
- Pharmacology 12
Countries citing papers authored by Adam Peyton
This map shows the geographic impact of Adam Peyton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam Peyton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam Peyton more than expected).
Fields of papers citing papers by Adam Peyton
This network shows the impact of papers produced by Adam Peyton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam Peyton. The network helps show where Adam Peyton may publish in the future.
Co-authors
The 9 scholars most cited alongside Adam Peyton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials Hit paper breakdown → | 2020 | 404 |
| 2 | Geriatric Interdisciplinary Team Training | 1999 | 10 |
| 3 | 2020 | 10 | |
| 4 | Sofosbuvir and Simeprevir Combination Therapy for HCV Genotype 1 Infection: Results of a Single-Center VA Experience. | 2016 | 2 |
| 5 | 2024 | 1 | |
| 6 | 2020 | 1 | |
| 7 | 2011 | 1 |
About Adam Peyton
Adam Peyton is a scholar working on Hepatology, Pulmonary and Respiratory Medicine, Gastroenterology, Clinical Biochemistry and Epidemiology, having authored 7 papers that have together received 429 indexed citations. Recurring topics across this work include Liver Diseases and Immunity (3 papers), Liver Disease Diagnosis and Treatment (2 papers), Gallbladder and Bile Duct Disorders (2 papers), Metabolism and Genetic Disorders (1 paper), Innovations in Medical Education (1 paper), Hepatitis C virus research (1 paper), Hepatitis B Virus Studies (1 paper) and Diet and metabolism studies (1 paper). The work is most often cited by research in Hepatology (157 citations), Epidemiology (311 citations), Endocrinology, Diabetes and Metabolism (106 citations), Cell Biology (63 citations) and Pharmacology (12 citations). Adam Peyton has collaborated with scholars based in United States. Frequent co-authors include Patricia W. Slattum, Rita A. Jablonski, Peter A. Boling, F. Ellen Netting, Iris A. Parham, Zamir Brelvi, Maria Del Pilar Solis Hernandez, Lennox J. Jeffers and Seth N. Sclair. Their work appears in journals such as Journal of Hepatology, Gastroenterology, The American Journal of Gastroenterology, Annals of Hepatology and VCU Scholars Compass (Virginia Commonwealth University).
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.